MedTrace Logo

Pharmacokinetic Profile of Rosemary Extract Supplement

NCT05931341 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-11-22

No results posted yet for this study

Summary

This study is a clinical trial to observe changes in biomarkers in the blood at pre- and post-supplementation of rosemary extract in healthy adults.

Conditions

  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

Rosemary extract

Softgel capsule including rosemary extract

Sponsors & Collaborators

  • CJ CheilJedang

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-03-01
Completion
2024-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05931341 on ClinicalTrials.gov